University of Vermont

The University of Vermont Cancer Center

trials_pedcontrol

Pediatric Cancer Control and Prevention Clinical Trials

Cancer Control and Prevention clinical trials are non-treatment trials. Examples of some aims of cancer control studies include: to reduce the risk, incidence, and deaths from cancer, to enhance the quality of life for cancer survivors, to study the cause and distribution of cancer, to develop effective interventions, or to monitor cancer trends in populations.

Status: Active - Recruiting
Study Title: ACCRN07: Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN)
Purpose: To obtain informed consent from parents of infants, children, adolescents, and young adults newly diagnosed with cancer (and their child when appropriate) to enter their names and certain information concerning their child . . . . into the Childhood Cancer Research Network.
ClinicalTrials.gov Identifier: NC701117168
Primary/Site/Co Investigator: Alan C. Homans
Contact: Alan Homans (802) 847-2850
Information: http://www.clinicaltrials.gov/ct2/show/NCT01117168?term=children%27s+oncology+group+registry&rank=1
Institution Number: 00-327 COG ACCRN07
Protocol Research Type: Cooperative Group
Status: Active - Recruiting
Study Title: ALTE03N1: Key Adverse Events after Childhood Cancer
Purpose: This clinical trial is studying cancer survivors to identify those who are at increased risk of developing late-occurring complications after undergoing treatment for childhood cancer.
ClinicalTrials.gov Identifier: NCT00082745
Primary/Site/Co Investigator: Alan C. Homans
Contact: Alan Homans (802) 847-2850
Information: http://www.clinicaltrials.gov/ct2/show/NCT00082745?term=COG+ALTE03N1&rank=1
Institution Number: 00-327 COG ALTE03N1
Protocol Research Type: Cooperative Group
Status: Active - Recruiting
Study Title: ALTE05N1: Umbrella Long-Term Follow-Up Study
Purpose: FC-6 is a Phase II, multi-center clinical trial for patients with unresectable, wild-type K-RAS, colorectal cancer with metastases confined to the liver. Liver metastases must be determined by FC-6 criteria to be unresectable, and the colorectal cancer (CRC) tumor (primary or metastatic) must be found to be wild-type K-RAS. Patients with mutant K-RAS tumors are ineligible. K-RAS testing can be done through the local hospital or a tumor sample can be submitted to the FC-6 central lab (Esoterix Clinical Trial Services).

A primary aim of this study is to evaluate the surgical conversion rate using cytotoxic combination chemotherapy and biologic therapy with cetuximab, a monoclonal antibody targeted against the epidermal growth factor receptor. A second primary aim is to evaluate the safety and tolerability of a chemotherapy/targeted therapy regimen in this patient population. Secondary aims include determination of clinical response rate, recurrence-free survival for patients undergoing complete resection and/or ablation of liver metastases, and overall survival.

ClinicalTrials.gov Identifier: NCT00736749
Primary/Site/Co Investigator: Alan C. Homans
Contact: Alan Homans (802) 847-2850
Information: http://www.clinicaltrials.gov/ct2/show/NCT00803647?term=NSABP+FC-6&rank=1
Institution Number: 00-327 COG ALTE05N1
Protocol Research Type: Cooperative Group
Status: Active - Recruiting
Study Title: ACCL0933: Fungal Infection in AML
Purpose: This randomized phase III clinical trial is studying caspofungin acetate to see how it works compared to fluconazole in preventing invasive fungal infections in patients with acute myeloid leukemia who are undergoing chemotherapy.
ClinicalTrials.gov Identifier: NCT01307579
Primary/Site/Co Investigator: Alan C. Homans
Contact: Alan Homans (802) 847-2850
Information: http://www.clinicaltrials.gov/ct2/show/NCT01307579?term=01307579&rank=1
Institution Number: 00-327 COG ALTE05N1
Protocol Research Type: Cooperative Group
Status: Active - Recruiting
Study Title: ALTE05N1: Late Effects after Transplant
Purpose: This clinical trial is studying long-term follow-up in patients who are or have participated in Children's Oncology Group studies.
ClinicalTrials.gov Identifier: NCT00736749
Primary/Site/Co Investigator: Alan C. Homans
Contact: Alan Homans (802) 847-2850
Information: http://www.clinicaltrials.gov/ct2/show/NCT00736749?term=00736749&rank=1
Institution Number: 00-327 COG ALTE05N1
Protocol Research Type: Cooperative Group

Last modified December 06 2013 11:14 AM